Daniel de Boer, CEO of ProQR Therapeutics, discusses the evolution of his company, its pipeline of antisense oligonucleotide therapies, and the advantage of this approach in treating rare eye diseases.

Using RNA Therapies to Target Inherited Retinal Diseases

<p>RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy. </p>

Business

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Share Using RNA Therapies to Target Inherited Retinal Diseases

Sign up to save your podcasts

Using RNA Therapies to Target Inherited Retinal Diseases

Using RNA Therapies to Target Inherited Retinal Diseases